Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.19 | -11.4457831325 | 1.66 | 1.7 | 1.47 | 2190013 | 1.56447527 | CS |
| 4 | -1.71 | -53.7735849057 | 3.18 | 3.46 | 1.26 | 3647550 | 1.70965255 | CS |
| 12 | -11.82 | -88.9390519187 | 13.29 | 13.71 | 1.26 | 2756659 | 3.20697826 | CS |
| 26 | -10.03 | -87.2173913043 | 11.5 | 16.1 | 1.26 | 1508479 | 5.09294671 | CS |
| 52 | -13.06 | -89.8830006882 | 14.53 | 16.52 | 1.26 | 977394 | 6.8993817 | CS |
| 156 | -6.03 | -80.4 | 7.5 | 36.64 | 1.26 | 829165 | 15.42438629 | CS |
| 260 | -21.03 | -93.4666666667 | 22.5 | 43.92 | 1.26 | 564837 | 16.17782179 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
